Document Detail

Inhibiting the inflammatory response in joint sepsis.
MedLine Citation:
PMID:  11239354     Owner:  NLM     Status:  Publisher    
PURPOSE: We created a rabbit model of infectious arthritis to test the effects of WRC-0470 (2-cyclohexylmethylidenehydarazinoadenosine), an adenosine analogue, and rolipram, a type IV phosphodiesterase inhibitor, on intra-articular white blood cell recruitment. Type of Study: Randomized trial involving mature rabbits. METHODS: Intra-articular injections ranging from 0 to 2,000 ng of Escherichia coli lipopolysaccharide (LPS) were tested as the infectious stimulus. The optimal LPS amount was determined based on synovial fluid analysis for white blood cell counts. A separate cohort of rabbits then received various intravenous concentrations of either rolipram, WRC-0470, or a combination of the 2 medications. Synovial fluid aspirations after a 6-hour incubation were analyzed for white blood cell counts. RESULTS: Intra-articular injections of 200 ng of LPS reproducibly generated an inflammatory response of 4,000 cells/mL of synovial fluid, establishing the use of this dose of LPS for our septic arthritis model. Following infusions of 10 µg/kg/min, the average white blood cell count dropped to 800 cells/mL for WRC-0470 (P <.01) and 1,225 cells/mL for rolipram (P <.05). A synergistic effect was seen with the combination of both medications at just 1.0 µg/kg/min, with a mean white blood cell count of 1,090 cells/mL (P <.01). CONCLUSIONS: Septic arthritis is a common clinical entity that frequently results in major long-term morbidity. Although bacteria can directly damage the articular surface, the cytokine-mediated immune response to the infection can exacerbate the insult by promoting the release of proteolytic enzymes by white blood cells. Currently, no established intervention exists that will decrease the inflammatory response to infectious challenges. Our study shows that WRC-0470 and rolipram effectively reduce the intra-articular recruitment of white blood cells in a septic arthritis model. Future investigations of these drugs will determine their ultimate degree of efficacy at limiting the joint destruction associated with septic arthritis.
Christopher J. Hogan; Guo-Dong Fang; W. Michael Scheld; Joel Linden; David R. Diduch
Related Documents :
16197994 - Cytotoxic and apoptogenic effect of tea (camellia sinensis var. assamica) root extract ...
8725664 - Sample preparation and in situ hybridization techniques for automated molecular cytogen...
19878524 - Procurement of spore-free bacillus anthracis for molecular typing outside of bsl3 envir...
18096934 - Short communication: outbreak of nocardia neocaledoniensis mastitis in an italian dairy...
403594 - Ligand-induced redistribution and augmentation of surface-bound myeloma protein on mopc...
2571624 - An immunohistochemical study of fibrous papule of the nose: 25 cases.
Publication Detail:
Journal Detail:
Title:  Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association     Volume:  17     ISSN:  1526-3231     ISO Abbreviation:  Arthroscopy     Publication Date:  2001 Mar 
Date Detail:
Created Date:  2001-Mar-9     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8506498     Medline TA:  Arthroscopy     Country:  -    
Other Details:
Languages:  ENG     Pagination:  311-315     Citation Subset:  -    
Departments of Orthopaedic Surgery (C.J.H., D.R.D.) and Infectious Diseases (G-D.F., W.M.S., J.L.), The University of Virginia School of Medicine, Charlottesville, Virginia, U.S.A.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Poor correlation of clinical signs with patellar cartilaginous changes.
Next Document:  Irreducible knee dislocation treated by arthroscopic debridement.